Abstract

As the editors of the Journal of Cachexia, Sarcopenia and Muscle (JCSM), we are proud to announce that the journal has maintained its impact factor, which has now been published by Thomson Scientific as 7.3, placing it number 9 in the ranking of all journals in the field ‘Medicine, General and Internal’ (Table 1) and number 3 among all nutrition journals, among which, however, JCSM is not offficially listed (Table 2). The number of submissions has increased over the last year, but because we decided to stick with four print issues per year, this also means that our rejection rate is now in excess of 80% of submitted articles. Indeed, at the time of this writing, on 9 July 2015, the journal has received 106 submissions in 2015 alone (Figure 1). We are working hard to provide a timely peer review, which is not always easy as it is difficult at times to find appropriate reviewers. In addition, the journal aims to cover not only clinical medicine but also basic research into cachexia, sarcopenia, and muscle pathophysiology in its broadest sense. Authors can help in speeding the review process by suggesting referees who are able to provide a balanced, however, unbiased comment. It does not come as a major surprise that among the best cited articles since the first publication of the JCSM are those that are available for the longest time, that is, those published in 2010 and 2011 (Table 3). Editorials like our ‘facts and numbers’ series that try to summarize knowledge of a specific field in a comprehensive way remain a publication type that we are very much in favour of. This is also highlighted by the popularity of editorials published in 2014 (Tables 4 and 5). We invite scientists to submit such editorials with as many facts and figures as possible on a topic of interest to our readership to submit their work for consideration. The authors of this manuscript certify that they comply with the principles of ethical publishing in the Journal of Cachexia, Sarcopenia and Muscle 2010;1:7–8 (von Haehling S, Morley JE, Coats AJ, and Anker SD). None declared.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.